AdvaMed: FDA Has Funds For Device Reviews Through Shutdown

By Christian Robles / October 8, 2025 at 4:20 PM

SAN DIEGO -- AdvaMed CEO Scott Whitaker said he believes FDA has enough user fee-supported reserve funds to conduct medical device reviews through the ongoing government shutdown, but he wants assurances from the agency those funds won’t be used for other purposes.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.